Benjamin R. Yerxa - 23 Oct 2026 Form 4 Insider Report for Opus Genetics, Inc. (IRD)

Reporting relationship: President, Director
Issuer ticker: IRD
Reported as of: 23 Oct 2026
Net transaction value: -$117,365
SEC form: 4
Accepted by SEC: 27 Oct 2026, 16:41:18 UTC
Prior SEC filing: 27 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Amy Rabourn, by Power of Attorney

Filing notes and source

Key filing fact

Benjamin R. Yerxa filed Form 4 for Opus Genetics, Inc. (IRD) on 27 Oct 2026.

Key facts

This page summarizes Benjamin R. Yerxa's Form 4 filing for Opus Genetics, Inc. (IRD).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 27 Oct 2026, 16:41.

Change

Previous filing in this sequence was filed on 27 Jul 2026.
Current net transaction value: -$117,365.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001145910 Primary reporting owner

YERXA BENJAMIN R

Relationship: President, Director
Address: C/O OPUS GENETICS, INC., 8 DAVIS DRIVE, SUITE 220, DURHAM
Signature: /s/ Amy Rabourn, by Power of Attorney
Signature date: 27 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IRD transaction

Common Stock

Sale

Transaction value: -$27,236
Shares: -7,669
Change %: -1.1%
Price: $3.55
Shares after: 696,437
Date: 23 Oct 2026
Ownership: Direct
Footnotes: F1, F2

IRD transaction

Common Stock

Sale

Transaction value: -$90,129
Shares: -25,520
Change %: -3.7%
Price: $3.53
Shares after: 670,917
Date: 23 Oct 2026
Ownership: Direct
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Issuer to satisfy tax withholding obligations that arose in connection with the vesting and settlement of restricted stock units. This transaction does not represent a discretionary trade by the Reporting Person.

Footnote F2

The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $3.5500 to $3.5522, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F3

The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $3.53 to $3.545, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.